1. Home
  2. XAIR vs SOND Comparison

XAIR vs SOND Comparison

Compare XAIR & SOND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XAIR
  • SOND
  • Stock Information
  • Founded
  • XAIR 2011
  • SOND 2014
  • Country
  • XAIR United States
  • SOND United States
  • Employees
  • XAIR N/A
  • SOND N/A
  • Industry
  • XAIR Medical/Dental Instruments
  • SOND Hotels/Resorts
  • Sector
  • XAIR Health Care
  • SOND Consumer Discretionary
  • Exchange
  • XAIR Nasdaq
  • SOND Nasdaq
  • Market Cap
  • XAIR 17.0M
  • SOND 17.2M
  • IPO Year
  • XAIR N/A
  • SOND N/A
  • Fundamental
  • Price
  • XAIR $2.50
  • SOND $1.26
  • Analyst Decision
  • XAIR Strong Buy
  • SOND
  • Analyst Count
  • XAIR 1
  • SOND 0
  • Target Price
  • XAIR $11.00
  • SOND N/A
  • AVG Volume (30 Days)
  • XAIR 466.2K
  • SOND 64.7K
  • Earning Date
  • XAIR 11-10-2025
  • SOND 11-03-2025
  • Dividend Yield
  • XAIR N/A
  • SOND N/A
  • EPS Growth
  • XAIR N/A
  • SOND N/A
  • EPS
  • XAIR N/A
  • SOND N/A
  • Revenue
  • XAIR $4,782,000.00
  • SOND $606,649,000.00
  • Revenue This Year
  • XAIR $263.75
  • SOND $46.47
  • Revenue Next Year
  • XAIR $148.43
  • SOND N/A
  • P/E Ratio
  • XAIR N/A
  • SOND N/A
  • Revenue Growth
  • XAIR 168.20
  • SOND N/A
  • 52 Week Low
  • XAIR $2.02
  • SOND $1.21
  • 52 Week High
  • XAIR $13.52
  • SOND $4.99
  • Technical
  • Relative Strength Index (RSI)
  • XAIR 52.02
  • SOND 28.51
  • Support Level
  • XAIR $2.16
  • SOND $1.21
  • Resistance Level
  • XAIR $2.53
  • SOND $1.37
  • Average True Range (ATR)
  • XAIR 0.13
  • SOND 0.15
  • MACD
  • XAIR 0.03
  • SOND -0.02
  • Stochastic Oscillator
  • XAIR 91.89
  • SOND 5.37

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

About SOND Sonder Holdings Inc.

Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.

Share on Social Networks: